The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands

McDonald SA, van Lier A, Plaß D, Kretzschmar MEE (2012)
Bmc Public Health 12(1): 1046.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
McDonald, Scott A.; van Lier, Alies; Plaß, DietrichUniBi; Kretzschmar, Mirjam E. E.
Abstract / Bemerkung
Background: For accurate estimation of the future burden of communicable diseases, the dynamics of the population at risk - namely population growth and population ageing - need to be taken into account. Accurate burden estimates are necessary for informing policy-makers regarding the planning of vaccination and other control, intervention, and prevention measures. Our aim was to qualitatively explore the impact of population ageing on the estimated future burden of seasonal influenza and hepatitis B virus (HBV) infection in the Netherlands, in the period 2000-2030. Methods: Population-level disease burden was quantified using the disability-adjusted life years (DALY) measure applied to all health outcomes following acute infection. We used national notification data, pre-defined disease progression models, and a simple model of demographic dynamics to investigate the impact of population ageing on the burden of seasonal influenza and HBV. Scenario analyses were conducted to explore the potential impact of intervention-associated changes in incidence rates. Results: Including population dynamics resulted in increasing burden over the study period for influenza, whereas a relatively stable future burden was predicted for HBV. For influenza, the increase in DALYs was localised within YLL for the oldest age-groups (55 and older), and for HBV the effect of longer life expectancy in the future was offset by a reduction in incidence in the age-groups most at risk of infection. For both infections, the predicted disease burden was greater than if a static demography was assumed: 1.0 (in 2000) to 2.3-fold (in 2030) higher DALYs for influenza; 1.3 (in 2000) to 1.5-fold (in 2030) higher for HBV. Conclusions: There are clear, but diverging effects of an ageing population on the estimated disease burden of influenza and HBV in the Netherlands. Replacing static assumptions with a dynamic demographic approach appears essential for deriving realistic burden estimates for informing health policy.
Stichworte
Disability-adjusted life-years; Disease burden; Hepatitis B; Population ageing; Influenza
Erscheinungsjahr
2012
Zeitschriftentitel
Bmc Public Health
Band
12
Ausgabe
1
Art.-Nr.
1046
ISSN
1471-2458
Page URI
https://pub.uni-bielefeld.de/record/2553333

Zitieren

McDonald SA, van Lier A, Plaß D, Kretzschmar MEE. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health. 2012;12(1): 1046.
McDonald, S. A., van Lier, A., Plaß, D., & Kretzschmar, M. E. E. (2012). The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health, 12(1), 1046. doi:10.1186/1471-2458-12-1046
McDonald, Scott A., van Lier, Alies, Plaß, Dietrich, and Kretzschmar, Mirjam E. E. 2012. “The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands”. Bmc Public Health 12 (1): 1046.
McDonald, S. A., van Lier, A., Plaß, D., and Kretzschmar, M. E. E. (2012). The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health 12:1046.
McDonald, S.A., et al., 2012. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health, 12(1): 1046.
S.A. McDonald, et al., “The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands”, Bmc Public Health, vol. 12, 2012, : 1046.
McDonald, S.A., van Lier, A., Plaß, D., Kretzschmar, M.E.E.: The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. Bmc Public Health. 12, : 1046 (2012).
McDonald, Scott A., van Lier, Alies, Plaß, Dietrich, and Kretzschmar, Mirjam E. E. “The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands”. Bmc Public Health 12.1 (2012): 1046.

9 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020.
Maertens de Noordhout C, Devleesschauwer B, Haagsma JA, Havelaar AH, Bertrand S, Vandenberg O, Quoilin S, Brandt PT, Speybroeck N., Euro Surveill 22(38), 2017
PMID: 28935025
Demographic trends and public health in Europe.
England K, Azzopardi-Muscat N., Eur J Public Health 27(suppl_4), 2017
PMID: 29028238
Burden of four vaccine preventable diseases in older adults.
Kristensen M, van Lier A, Eilers R, McDonald SA, Opstelten W, van der Maas N, van der Hoek W, Kretzschmar ME, Nielen MM, de Melker HE., Vaccine 34(7), 2016
PMID: 26752065
Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.
van Lier A, McDonald SA, Bouwknegt M, EPI group, Kretzschmar ME, Havelaar AH, Mangen MJ, Wallinga J, de Melker HE., PLoS One 11(4), 2016
PMID: 27097024
Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J., BMJ 350(), 2015
PMID: 25985328
Forecasting and Analyzing the Disease Burden of Aged Population in China, Based on the 2010 Global Burden of Disease Study.
Bao C, Mayila M, Ye Z, Wang J, Jin M, He W, Chen K., Int J Environ Res Public Health 12(7), 2015
PMID: 26121188
An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands.
McDonald SA, Presanis AM, De Angelis D, van der Hoek W, Hooiveld M, Donker G, Kretzschmar ME., Influenza Other Respir Viruses 8(1), 2014
PMID: 24209610
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany.
Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, Schmidt-Ott R., BMC Infect Dis 14(), 2014
PMID: 24993051
Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands.
McDonald SA, Mangen MJ, Suijkerbuijk A, Colzani E, Kretzschmar ME., BMC Infect Dis 13(), 2013
PMID: 23497182

37 References

Daten bereitgestellt von Europe PubMed Central.


AUTHOR UNKNOWN, 2011

AUTHOR UNKNOWN, 2008
Infections in the elderly.
Liang SY, Mackowiak PA., Clin. Geriatr. Med. 23(2), 2007
PMID: 17462528
Natural history and prognosis of hepatitis B.
Fattovich G., Semin. Liver Dis. 23(1), 2003
PMID: 12616450
Chronic hepatitis B.
Lok AS, McMahon BJ., Hepatology 45(2), 2007
PMID: 17256718
The global impact of influenza on morbidity and mortality.
Simonsen L., Vaccine 17 Suppl 1(), 1999
PMID: 10471173
Mortality associated with influenza and respiratory syncytial virus in the United States.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K., JAMA 289(2), 2003
PMID: 12517228

AUTHOR UNKNOWN, 2011
Complications of viral influenza.
Rothberg MB, Haessler SD, Brown RB., Am. J. Med. 121(4), 2008
PMID: 18374680
New methodology for estimating the burden of infectious diseases in Europe.
Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fevre EM, Longhi S, Lai T, Havelaar AH, Stein C, Cassini A, Kramarz P; BCoDE consortium, Havelaar A, Kretzschmar M, van Lier A, McDonald S, Brooke J, Haagsma J, Mangen MJ, de Wit A, Kramer A, Pinheiro P, Plass D, Fevre E, Gibbons C, Franco E, Longhi S, Ricciardi W, de Waure C, Jahn B, Muhlberger N, Siebert U, Lai T, Matsi A, Ruutel K, Cassini A, Colzani E, Kramarz P, Achterberg P, Amato A, Coutinho R, Nanda A, Salminen M, Vos T., PLoS Med. 9(4), 2012
PMID: 22529750
The burden of infectious diseases in Europe: a pilot study.
van Lier EA, Havelaar AH, Nanda A., Euro Surveill. 12(12), 2007
PMID: 18076860

AUTHOR UNKNOWN, 1996
Comparison of three methods for selecting values of input variables in the analysis of output from a computer code
AUTHOR UNKNOWN, 1979

AUTHOR UNKNOWN, 2011

AUTHOR UNKNOWN, 2011
The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis.
Alter MJ, Mares A, Hadler SC, Maynard JE., Am. J. Epidemiol. 125(1), 1987
PMID: 3098091
Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996.
Ramsay ME, Balogun MA, Collins M, Balraj V., Commun Dis Public Health 1(2), 1998
PMID: 9644120

AUTHOR UNKNOWN, 2001

AUTHOR UNKNOWN, 2009
The burden of 2009 pandemic influenza A(H1N1) in the Netherlands.
Wielders CC, van Lier EA, van 't Klooster TM, van Gageldonk-Lafeber AB, van den Wijngaard CC, Haagsma JA, Donker GA, Meijer A, van der Hoek W, Lugner AK, Kretzschmar ME, van der Sande MA., Eur J Public Health 22(1), 2010
PMID: 21183472

AUTHOR UNKNOWN, 2011

AUTHOR UNKNOWN, 2006
Viral shedding and clinical illness in naturally acquired influenza virus infections.
Lau LL, Cowling BJ, Fang VJ, Chan KH, Lau EH, Lipsitch M, Cheng CK, Houck PM, Uyeki TM, Peiris JS, Leung GM., J. Infect. Dis. 201(10), 2010
PMID: 20377412
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom.
Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H., Eur. J. Clin. Microbiol. Infect. Dis. 19(11), 2000
PMID: 11152308
Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project.
Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, Larrauri A, Meijer A, Puzelli S, Rizzo C, Simonsen L; EPIA collaborators, Balderston C, Bella A, Perez-Brena P, Casas I, Cuadrado TL, de Mateo S, Donatelli I, Donker G, Edelman L, Elliot A, Fleming D, Glisman S, Heikkinen T, Larrauri A, de Lejarazu Leonardo RO, Mazick A, McMenamin J, Meijer A, Molbak K, Nielsen L, Paget J, Pnaiser R, Pregliasco F, Puzelli S, Reynolds A, Rizzo C, Simonsen L, Smith D, Sune TP, van der Sande M, Alonso TV, Vesikari T, Watson J, Weil-Olivier C, Zambon M, Ziegler T., Eur. J. Pediatr. 169(8), 2010
PMID: 20229049
Long time trends in influenza-like illness and associated determinants in The Netherlands.
Dijkstra F, Donker GA, Wilbrink B, Van Gageldonk-Lafeber AB, Van Der Sande MA., Epidemiol. Infect. 137(4), 2008
PMID: 18789176
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.
Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K., J. Infect. Dis. 178(1), 1998
PMID: 9652423
Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children.
Wijngaard CC, Asten Lv, Koopmans MP, Pelt Wv, Nagelkerke NJ, Wielders CC, Lier Av, Hoek Wv, Meijer A, Donker GA, Dijkstra F, Harmsen C, Sande MA, Kretzschmar M., PLoS ONE 7(2), 2012
PMID: 22319616

AUTHOR UNKNOWN, 2011
Projections of global mortality and burden of disease from 2002 to 2030.
Mathers CD, Loncar D., PLoS Med. 3(11), 2006
PMID: 17132052
[Effects of ageing on infectious disease].
Bijkerk P, van Lier EA, van Vliet JA, Kretzschmar ME., Ned Tijdschr Geneeskd 154(), 2010
PMID: 20977793
Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.
Hahne SJ, De Melker HE, Kretzschmar M, Mollema L, Van Der Klis FR, Van Der Sande MA, Boot HJ., Epidemiol. Infect. 140(8), 2011
PMID: 22078095
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK, Toy M, Hahne SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH., Gastroenterology 138(2), 2009
PMID: 19879275
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 23217094
PubMed | Europe PMC

Suchen in

Google Scholar